State Of Wyoming Chinook Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $604 - $902	48 Added 31.79%	199 $3,000
Q1 2022 May 13, 2022	BUY	$12.02 - $16.69 $588 - $817	49 Added 48.04%	151 $2,000
Q4 2021 Feb 11, 2022	BUY	$10.69 - $16.83 $438 - $690	41 Added 67.21%	102 $2,000
Q3 2021 Feb 11, 2022	SELL	$11.5 - $14.86 $23 - $29	-2 Reduced 3.17%	61 $1,000
Q2 2021 Feb 11, 2022	BUY	$13.6 - $18.98 $856 - $1,195	63 New	63 $1,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.